COPPELL, Texas, Nov. 21, 2014 (GLOBE NEWSWIRE) -- ZS Pharma ( ZSPH ), a biopharmaceutical company developing novel treatments for kidney, cardiovascular, liver and metabolic disorders, today announced the publication of previously unreleased ... Yahoo! Finance, 2 days ago
Keryx Biopharmaceuticals Announces Results From Ferric Citrate Phase 3 Long-Term Safety Extension St … - Yahoo! Finance, 1 week ago
A new study shows that having later sunsets leads to an increase in children's physical activity, even when taking into account weather conditions and temperature. Researchers at the London School of Hygiene & Tropical Medicine (LSHTM; United ...Hospi Medica, 2 weeks ago
Journal of Nuclear Cardiology Publication States Preliminary Findings of Phase II Clinical Study Suggest …
) - FluoroPharma Medical, Inc. ( FPMI ) , a company specializing in the development of novel diagnostic imaging products that utilize positron emission tomography (PET) technology for the detection and assessment of disease before clinical ...Yahoo! Finance, 2 weeks ago
OPKO HEALTH : Announces Publication of Large, Prospective, Multi-Institutional Clinical Validation of the 4Kscore Test for High Grade Prostate Cancer in the...
OPKO Announces Publication of Large, Prospective, Multi-Institutional Clinical Validation of the 4Kscore Test for High Grade Prostate Cancer in the United States By a News Reporter-Staff News Editor at Clinical Trials Week -- OPKO Health, Inc.4 Traders, 4 days ago OPKO Announces Publication of Large, Prospective, Multi-Institutional Clinical Validation of the 4Kscore(TM) Test for High Grade Prostate Cancer in the United States Scottrade, 1 week ago
Elsevier's European Journal of Medical Genetics Joins DECIPHER Project to Enhance Exome Data Sharing
/PRNewswire/ -- Direct linking between exome data in DECIPHER and European Journal of Medical Genetics' Exome Report article Elsevier, a world-leading provider of scientific, technical and medical information products and services, announces the ...Scottrade, 6 days ago
SANOFI : Sanofi and Regeneron Announce Positive Results.. 03 Nov - The New England Journal of Medicine Publishes Results o.. 29 Oct - Statement from Sanofi Board of Directors Related debate 11 Nov - It is very respective and ...EuroInvestor, 1 week ago Regeneron (REGN), Sanofi (SAN.PA) Eczema Drug Dupilumab Gets FDA Breakthrough Therapy Designation 11/20/2014 ClinicSpace, 3 days ago REG-Sanofi : Sanofi and Regeneron Announce that Dupilumab Has Received FDA Breakthrough Therapy Designation in Atopic Dermatitis Reuters, 3 days ago Regeneron and Sanofi Announce that Dupilumab Has Received FDA Breakthrough Therapy Designation in Atopic Dermatitis MoneyShow.com, 3 days ago
More from: Reuters, Minyanville...and 41 other sources
, says NZ importer Auckland-based European food importing business William Aitken & Co is delighted a publication authored by several senior international medical figures in the latest prestigious Postgraduate Medical Journal encourages people to ...Scoop, 4 days ago
PUBLIC RELEASE DATE: 18-Nov-2014 People with airway diseases, including asthma and chronic obstructive pulmonary disease (COPD), have a higher incidence of inflammatory bowel disease, such as Crohn's disease and ulcerative colitis, according to ...EurekAlert!, 5 days ago Majority of people -- including health professionals -- struggle to identify obesity EurekAlert!, 1 week ago
Do you want more freelance work with a 30-day payment guarantee? Register your interest in Content Cloud (free for journalists) and enter a draw to win an iPad mini. Promoted jobs Editor of bi-monthly magazine forLions Clubs International ...Press Gazette, 1 week ago
PUBLIC RELEASE DATE: 12-Nov-2014 The loss of eyesight, often caused by retinal degeneration, is a life-altering health issue for many people, especially as they age. But a new development toward a prosthetic retina could help counter conditions ...EurekAlert!, 1 week ago
on your WebpageAdd Widget >Get your members hooked!